1140 companies

Alterola Biotech

Market Cap: US$296.3k

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

ABTI

US$0.0002

7D

0%

1Y

-95.0%

IMAC Holdings

Market Cap: US$265.3k

Through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States.

BACK

US$0.074

7D

2.2%

1Y

-93.6%

RegeneRx Biopharmaceuticals

Market Cap: US$242.9k

A biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration.

RGRX

US$0.16

7D

0%

1Y

11,400.0%

Panbela Therapeutics

Market Cap: US$242.7k

A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.

PBLA

US$0.05

7D

-0.2%

1Y

-84.8%

CNBX Pharmaceuticals

Market Cap: US$226.0k

A clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer.

CNBX

US$0.00035

7D

16.7%

1Y

-94.7%

Synairgen

Market Cap: US$220.5k

Synairgen plc discovers and develops drugs for respiratory diseases.

SYGG.F

US$0.0002

7D

100.0%

1Y

-99.5%

Beroni Group

Market Cap: US$217.5k

Develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics, and viral diagnostic kits in China.

BNIG.F

US$0.0064

7D

0%

1Y

n/a

Vincerx Pharma

Market Cap: US$209.4k

Operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States.

VINC

US$0.049

7D

22.6%

1Y

-99.6%

Greater Cannabis Company

Market Cap: US$202.5k

Engages in the development and commercialization of cannabinoid therapeutics.

GCAN

US$0.0003

7D

87.5%

1Y

-40.0%

Tian'an Pharmaceutical

Market Cap: US$196.1k

Develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China.

TNPH

US$0.0024

7D

0%

1Y

n/a

PAO Group

Market Cap: US$191.0k

Focuses on alternative patient care treatments.

PAOG

US$0.0001

7D

-50.0%

1Y

-75.0%

Allstar Health Brands

Market Cap: US$179.8k

A specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas.

ALST

US$0.00055

7D

-8.3%

1Y

-21.4%

GNCC Capital

Market Cap: US$174.1k

Through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils.

GNCP

US$0.000001

7D

0%

1Y

0%

ViaDerma

Market Cap: US$123.4k

Operates as a specialty pharmaceutical company in the United States.

VDRM

US$0.0002

7D

0%

1Y

-96.3%

Ampio Pharmaceuticals

Market Cap: US$121.7k

A biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.

AMPE

US$0.0027

7D

0%

1Y

22.7%

Endonovo Therapeutics

Market Cap: US$120.7k

A biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine.

ENDV

US$0.0001

7D

0%

1Y

-92.3%

Woodbrook Group Holdings

Market Cap: US$99.4k

Provides investment and strategic planning advisory services.

WDBG

US$0.0003

7D

0%

1Y

-99.5%

Medicine Man Technologies

Market Cap: US$85.6k

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

SHWZ

US$0.001

7D

-50.0%

1Y

-99.1%

Zhengduozhe Technology

Market Cap: US$84.1k

Zhengduozhe Technology, Inc, doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings.

ZDZT

US$1.92

7D

0%

1Y

-68.0%

GB Sciences

Market Cap: US$81.4k

A plant-based research and biopharmaceutical drug development company.

GBLX

US$0.0002

7D

100.0%

1Y

-96.7%

Syros Pharmaceuticals

Market Cap: US$79.2k

A biopharmaceutical company, focuses on the development of treatment for hematologic malignancies.

SYRS

US$0.0001

7D

-83.3%

1Y

-100.0%

MabCure

Market Cap: US$78.1k

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.

MBCI

US$0.0001

7D

0%

1Y

n/a

Nouveau Life Pharmaceuticals

Market Cap: US$66.6k

A development stage company, engages in the development of nutraceuticals products.

NOUV

US$0.000001

7D

0%

1Y

-99.0%

U.S. Stem Cell

Market Cap: US$66.2k

A biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States.

USRM

US$0.0001

7D

0%

1Y

9,900.0%

Affymax

Market Cap: US$59.6k

Does not have significant operations.

AFFY

US$0.0009

7D

12.5%

1Y

28.6%

Immunotech Laboratories

Market Cap: US$57.5k

Develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders.

IMMB

US$0.0001

7D

0%

1Y

n/a

Bright Green

Market Cap: US$57.3k

Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.

BGXX.Q

US$0.0008

7D

-75.0%

1Y

-98.5%

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.

HENC

US$0.0001

7D

0%

1Y

9,900.0%

Mera Pharmaceuticals

Market Cap: US$53.7k

Focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology.

MRPI

US$0.0001

7D

0%

1Y

n/a

Cannonau

Market Cap: US$48.4k

Engages in the provision of cannabidiol based products.

CNNC

US$0.0002

7D

-33.3%

1Y

-90.0%

Medican Enterprises

Market Cap: US$46.5k

A bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector.

MDCN

US$0.000001

7D

0%

1Y

0%

Plandaí Biotechnology

Market Cap: US$44.9k

Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.

PLPL

US$0.0001

7D

9,900.0%

1Y

0%

Itoco

Market Cap: US$42.8k

Engages in the processing, production, and distribution of medical cannabis products.

ITMC

US$0.0001

7D

0%

1Y

-96.8%

Emergent Health

Market Cap: US$42.7k

Develops and sells regenerative medicine, neutraceuticals, and phytonutritionals.

EMGE

US$0.0001

7D

0%

1Y

-92.3%

Oncology Pharma

Market Cap: US$42.5k

An oncology company, develops, manufactures, and commercializes therapeutics.

ONPH

US$0.0011

7D

174.3%

1Y

109,900.0%

Sunset Island Group

Market Cap: US$34.4k

Through its subsidiary, VBF Brands, engages in the cultivation of medical cannabis in California, the United States.

SIGO

US$0.0001

7D

0%

1Y

9,900.0%

Page 26 of 32